Showing results (901-910 of 999) with videos related to

Sort By:
Pageof 100
JACC. Advances|March 27, 2026
Lp(a) Has Specific Effects on Coronary Artery Disease Independent of LDL-C: A Mendelian Randomization StudyMoa P Lee, Sarah H Koenigsberg, Mohammad Y Anwar, et al.
The American Journal of Cardiology|February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)Aliza Hussain, Olive Tang, Caroline Sun, et al.
Journal of the American Heart Association|March 9, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCIBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
JAMA Cardiology|May 16, 2021
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH TrialSteven E Nissen, A Michael Lincoff, Kathy Wolski, et al.
Vascular Medicine (London, England)|September 6, 2024
Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart StudyAliza Hussain, Michelle C Johansen, Michael J Blaha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 22, 2021
Upper Reference Limits for High-Sensitivity Cardiac Troponin T and N-Terminal Fragment of the Prohormone Brain Natriuretic Peptide in Patients With CKDNisha Bansal, Leila R Zelnick, Christie M Ballantyne, et al.
Circulation|November 5, 2020
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization AnalysesBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
The American Journal of Cardiology|January 27, 2005
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid RegistryAudrey H Wu, Christie M Ballantyne, Beth C Short, et al.
European Heart Journal|January 13, 2022
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular riskJean-Claude Tardif, Ewa Karwatowska-Prokopczuk, Eric St Amour, et al.
JAMA Network Open|February 14, 2022
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin TreatmentWilliam S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Pageof 100